Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP39 activates Metastatic Cells Vitro potential contribution USP39 metastatic capacity A549 HCC827 cells performed Matrigel non-coated Transwell migration coated Transwell invasion assays. 1 / 1

| 1

➶

eidos

"Knockdown of USP39 Inhibits Metastatic of Lung Cancer Cells In Vivo and In Vitro To test the potential contribution of USP39 to the metastatic capacity of A549 and HCC827 cells , in vitro , we performed Matrigel non-coated Transwell migration and Matrigel coated Transwell invasion assays ."

33255748

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...